©The Author(s) 2025.
World J Gastroenterol. Dec 14, 2025; 31(46): 112530
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.112530
Published online Dec 14, 2025. doi: 10.3748/wjg.v31.i46.112530
Table 3 Hepatocellular carcinoma characteristics including possible cause, tumor size, treatment and response in the hepatocellular carcinoma group
| Variables | n | % | |
| Possible cause | HCV | 25 | 83.3 |
| HBV | 2 | 6.7 | |
| Unknown | 3 | 10.0 | |
| HCC treatment | TACE | 24 | 80.0 |
| RF | 6 | 20.0 | |
| Response | Complete | 16 | 53.3 |
| Partial | 14 | 46.7 | |
| Size (cm2) | Median (1st-3rd IQ) | 26.3 (8.4-59.3) | |
| Range | 1.2-138.0 | ||
- Citation: El-Nakeep S, AbdelAziz H, Michael TG, ElGhandour AM, Abdelsattar HA, Awad FMR, Kasi A. Clinical utility of telomeres as diagnostic and short-term prognostic markers in loco-regional treatment of hepatocellular carcinoma. World J Gastroenterol 2025; 31(46): 112530
- URL: https://www.wjgnet.com/1007-9327/full/v31/i46/112530.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i46.112530